耗材描述
TT-232
产品活性:TT-232 (CAP-232),一种生长抑素衍生物,是一种多肽类SSTR1/SSTR4 激动剂。TT-232 抑制癌细胞增殖并诱导细胞凋亡 (apoptosis)。TT-232 也是一种广谱抗炎镇痛剂。
产品来源: https://www.medchemexpress.cn/tt-232.html
研究领域:GPCR/G Protein | Neuronal Signaling
作用靶点:Somatostatin Receptor
In Vitro: TT-232 (10 μg/mL, 48 h) induces apoptosis in human colon (HT-29 and SW620), pancreatic (818), leukemia (K-562), melanoma (WM 938/B, M-1 and EP) and lymphoma (HT-58) tumor cell lines.
TT-232 (20-30 μg/mL, 24 h) shows antiproliferative effect on various human tumor cell lines.
In Vivo: TT-232 (15-750 μg/kg/day, twice a day) inhibits tumor growth in mice transplanted with Colon 26 cell.
TT-232 (0.6 or 15 μg/kg s.c or i.p.) shows antitumor effect on P-388 rodent lymphocytic leukemia tumor mice.
TT-232 (7.5-20 μg/kg, i.v.) inhibits Carrageenin-induced paw oedema in rats.
相关产品:Drug Repurposing Compound Library Plus | Clinical Compound Library Plus | Bioactive Compound Library Plus | Peptide Library | Octreotide | Cortistatin-14 | Pasireotide acetate | MK-4256 | CYN 154806 TFA | Cyclosomatostatin | AGI-41998 | Paltusotine | SSTR5 antagonist 1 | Pasireotide ditrifluoroacetate | BIM-23056 | J-2156 TFA | SSTR5 antagonist 2 hydrochloride | AGI-43192 | DOTA-LM3 TFA | CH 275 | PRL 2915 | Cortistatin 29 | BIM-23190 hydrochloride | L-803087 | Veldoreotide | Angiopeptin TFA | DOTA-JR11 | L-817818
品牌介绍: MCE (MedChemExpress) 拥有数百种全球独家化合物,我们致力于为全球科研客户提供最新最全的高品质小分子活性化合物;10,000 多种高选择性抑制剂、激动剂涉及各热门信号通路及疾病领域;设有专业的实验中心和严格的质控、验证体系;提供 LC/MS、NMR、HPLC、手性分析、元素分析等各项质检报告,确保产品的高纯度、高品质;产品的生物活性多经各国客户实验验证;Nature, Cell, Science 等多种顶级期刊及制药专利收录了MCE客户的科研成果;专业团队跟踪最新的制药及生命科学研究进展,为您提供全球最新的活性化合物;与世界各大制药公司及知名科研机构建立了长期的合作。